T

    Tourmaline Bio Inc. (TRML)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $47.98
    +0.00 (+0.00%)

    Market Cap: $1.23B

    Last updated: Aug 28, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    39%(7/18)
    Avg Surprise
    -571.53%
    Streak
    6 Q
    PeriodReportedEst.SurpriseB/MYoY
    Jun 25
    		$-0.90$-0.91+1.10%Beat-32.4%
    Mar 25
    		$-0.89$-0.94+4.95%Beat-61.8%
    Dec 24
    		$-0.86$-0.87+1.15%Beat-6.2%
    Sep 24
    		$-0.78$-0.82+4.88%Beat+52.5%
    Jun 24
    		$-0.68$-0.71+4.23%Beat+80.5%
    Mar 24
    		$-0.55$-0.67+17.91%Beat-48.6%
    Dec 23
    		$-0.81$-0.79-2.53%Miss+84.4%
    Sep 23
    		$-1.64$-0.60-173.68%Miss+64.3%
    Jun 23
    		$-3.49$-0.20-1647.35%Miss+20.6%
    Mar 23
    		$-0.37$-0.46+18.68%Beat+91.8%
    Dec 22
    		$-5.20$-0.49-961.22%Miss-48.6%
    Sep 22
    		$-4.60$-0.45-913.22%Miss-43.7%
    Jun 22
    		$-4.40$-0.46-867.03%Miss-7.3%
    Mar 22
    		$-4.50$-0.38-1074.02%Miss+65.4%
    Dec 21
    		$-3.50$-0.38-829.12%Miss-2087.5%
    Sep 21
    		$-3.20$-0.35-814.29%Miss-
    Jun 21
    		$-4.10$-0.26-1476.92%Miss-
    Mar 21
    		$-13.00$-0.77-1581.11%Miss-
    Dec 20
    		$-0.16$0.00N/AMiss-

    Dividends

    Dividend Metrics

    Yield0.00%
    Annual/Share$0.00

    Key Metrics

    Valuation
    P/E Ratio-13.99EV/EBITDA-281.95x
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-29.60%ROIC-29.91%
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio24.68xQuick Ratio24.68x
    Trading Statistics
    Beta1.58Avg VolumeN/A
    52-Week High$48.2752-Week Low$23.05

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$47.98
    SMA 20$47.98
    SMA 50$47.98
    SMA 200$44.58
    EMA 10$47.98
    EMA 20$47.98
    EMA 50$47.95
    EMA 200$42.54

    MACD

    Line: N/ASignal: 0.00Hist: N/A

    ADX

    ADX: 84.1+DI: 58.8-DI: 5.1

    Aroon & PSAR

    Aroon Up100.0
    Aroon Down100.0
    PSAR$47.97

    Bollinger Bands

    Upper Band$47.98
    Lower Band$47.98
    %B PositionN/A
    Band Width-32.00

    RSI (14-Day)

    Overbought
    89.3

    Momentum Oscillators

    Stoch %KN/A
    Stoch %DN/A
    Williams %RN/A
    ROC (10d)N/A
    MomentumN/A
    CCI (20d)N/A
    MFI (14d)N/A

    Volatility Measures

    ATR (14d)N/A
    StdDev (20d)N/A
    Hist VolN/A

    Volume Flow

    VWAP$47.98
    OBV30.5M
    AD Line4.1M
    CMF (20d)N/A

    Volume Metrics

    Avg Vol (20d)N/A
    Vol RatioN/A
    VWMA (20d)N/A

    Pivot Points

    R3$47.98
    R2$47.98
    R1$47.98
    Pivot Point$47.98
    S1$47.98
    S2$47.98
    S3$47.98

    Advanced Oscillators

    TSI78.37
    Ultimate OscN/A
    KSTN/A

    Financial Data

    QuarterJun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022
    Total Revenue$0$0$40,000$0$0$0$2.28M$0$0$0$0$0
    Cost of Revenue$0$0$20,000$0$0$0$1.14M$0$0$0$553,000$0
    Gross Profit$0$0$20,000$0$0$0$1.14M$0$0$0$-553,000$0
    Operating Expenses$25.97M$26.23M$25.81M$24.44M$21.97M$17.52M$14.89M$6.64M$16.37M$7.50M$-36,951,000$19.82M
    R&D$19.63M$20.26M$20.55M$19.33M$15.73M$11.38M$8.02M$3.76M$14.45M$6.14M$-24,838,000$14.98M
    SG&A$6.34M$5.97M$5.26M$5.11M$6.24M$6.14M$6.88M$2.88M$1.92M$1.36M$-12,113,000$4.84M
    Operating Income$-25,974,000$-26,231,000$-25,806,000$-24,438,000$-21,971,000$-17,517,000$-14,890,000$-6,643,000$-16,374,000$-7,502,000$36.95M$-19,823,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$812,000
    Interest Expense$0$0$12.95M$0$0$0$245,000$0$0$0$1.21M$0
    Income Before Tax$-25,974,000$-26,231,000$-38,757,000$-20,177,000$-21,971,000$-13,311,000$-15,135,000$-6,643,000$-16,129,000$-7,502,000$35.74M$-19,090,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-23,092,000$-22,970,000$-22,235,000$-20,177,000$-17,487,000$-13,311,000$-12,902,000$-5,591,000$-16,129,000$-7,502,000$35.66M$-19,011,000
    EBITDA$-27,397,000$-27,781,000$-27,769,000$-22,318,000$-24,251,000$-14,482,000$-15,401,000$-6,695,000$-16,093,000$-7,464,000$35.97M$-19,861,000
    EBIT$-25,974,000$-26,231,000$-25,806,000$-20,177,000$-21,971,000$-13,311,000$-14,890,000$-6,643,000$-16,129,000$-7,502,000$36.95M$-19,902,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about TRML

    News

    No news available

    Company news will appear here when available

    Frequently Asked Questions About TRML

    Does TRML pay dividends?
    Tourmaline Bio Inc. (TRML) has a dividend payment track record. See the TRML dividend history page for its current payment status, yield, and streaks.
    What is TRML's market cap?
    Tourmaline Bio Inc. (TRML) has a market capitalization of $1.23B with a current stock price of $47.98.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In